Dr. Robin Carhart-Harris is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco, where he leads a psychedelic research program. He obtained a PhD in Psychopharmacology from the University of Bristol in 2008 and founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for severe mental illnesses including depression and anorexia; he has authored over 160 papers, with over 21K citations, and in 2021, was named in TIME magazine’s ‘100 Next’ – a list of 100 rising stars shaping the future.